86 related articles for article (PubMed ID: 1036940)
21. [Effect of fluocortin butylester (0.75%) as an ointment in the pyrexal erythema test on human skin (author's transl)].
Heite HJ; Etspüler J
Arzneimittelforschung; 1977; 27(11a):2234-5. PubMed ID: 580035
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics and biotransformation following topical use of the local corticoid prednicarbate].
Kellner HM; Eckert HG; Fehlhaber HW; Hornke I; Oekonomopulos R
Z Hautkr; 1986; 61 Suppl 1():18-40. PubMed ID: 3705671
[TBL] [Abstract][Full Text] [Related]
23. [Human-pharmacokinetic Studies on Penetration Kinetics of a 6 alpha-Fluoro-9 alpha-chloro-16 alpha-methyl-delta 1,4-pregnadiene-11 beta-dihydroxy-3,20-dione-21-trimethyl-acetic acid (Clocortolone Trimethyl-acetic acid) after e picutaneous application].
Kolb KH; Latza R; Hepp-Latza O; Lücker PW; Rindt W; Simon B
Arzneimittelforschung; 1978; 28(9):1648-51. PubMed ID: 582571
[TBL] [Abstract][Full Text] [Related]
24. [Dermal and systemic side effects of fluocortin butylester. Comparative skin tearing experiments with active principles from commercial preparations].
Kapp JF; Gliwitzki B; Josefiuk P; Weishaupt W
Arzneimittelforschung; 1977; 27(11a):2206-13. PubMed ID: 580030
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo.
Wester RC; Melendres J; Sedik L; Maibach H; Riviere JE
Toxicol Appl Pharmacol; 1998 Jul; 151(1):159-65. PubMed ID: 9705899
[TBL] [Abstract][Full Text] [Related]
26. [Bioavailability of isoconazole in the skin (author's transl)].
Täuber U; Rzadkiewicz M
Mykosen; 1979 Jun; 22(6):201-16. PubMed ID: 460303
[No Abstract] [Full Text] [Related]
27. Topical Corticosteroids International Symposium, Venice, May 1972. Introductory remarks.
Craps L
Acta Derm Venereol Suppl (Stockh); 1973; 53():9-11. PubMed ID: 4585162
[No Abstract] [Full Text] [Related]
28. Animal studies with topical steroids.
Weidmann H
Acta Derm Venereol Suppl (Stockh); 1973; 53():25-7. PubMed ID: 4518659
[No Abstract] [Full Text] [Related]
29. [The percutaneous absorption of diclofenac].
Riess W; Schmid K; Botta L; Kobayashi K; Moppert J; Schneider W; Sioufi A; Strusberg A; Tomasi M
Arzneimittelforschung; 1986 Jul; 36(7):1092-6. PubMed ID: 3768079
[TBL] [Abstract][Full Text] [Related]
30. [Penetration of a non-steroidal anti-inflammatory drug into human skin in vitro and in vivo. Tissue concentrations and flow rates of p-butoxyphenylacetohydroxamic acid (author's transl)].
Schaefer H; Stüttgen G
Arzneimittelforschung; 1978; 28(6):1021-3. PubMed ID: 581998
[TBL] [Abstract][Full Text] [Related]
31. Aspects of pharmacodynamics and biotransformation of the glucocorticoid resocortol butyrate.
Coert A; Verheijen F; Horspool LJ; Mol JA
J Vet Pharmacol Ther; 2004 Oct; 27(5):309-15. PubMed ID: 15500568
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacolinetics and biotransformation of fluocortin butylester in man (author's transl)].
Mützel W
Arzneimittelforschung; 1977; 27(11a):2230-3. PubMed ID: 580034
[No Abstract] [Full Text] [Related]
33. Mometasone furoate degradation and metabolism in human biological fluids and tissues.
Teng XW; Cutler DJ; Davies NM
Biopharm Drug Dispos; 2003 Nov; 24(8):321-33. PubMed ID: 14595701
[TBL] [Abstract][Full Text] [Related]
34. Skin permeation and ex vivo skin metabolism of O-acyl haloperidol ester prodrugs.
Morris AP; Brain KR; Heard CM
Int J Pharm; 2009 Feb; 367(1-2):44-50. PubMed ID: 18845232
[TBL] [Abstract][Full Text] [Related]
35. Disposition and metabolism of fenbufen in several laboratory animals.
Chiccarelli FS; Eisner HJ; Van Lear GE
Arzneimittelforschung; 1980; 30(4A):707-15. PubMed ID: 6776965
[TBL] [Abstract][Full Text] [Related]
36. Local anti-inflammatory activity and systemic side effects of NM-135, a new prodrug glucocorticoid, in an experimental inflammatory rat model.
Ishii T; Kibushi N; Nakajima T; Kakuta T; Tanaka N; Sato C; Sugai K; Kijima-Suda I; Kai H; Miyata T
Jpn J Pharmacol; 1998 Dec; 78(4):505-9. PubMed ID: 9920209
[TBL] [Abstract][Full Text] [Related]
37. Prospects for future topical glucocorticoid development.
Brattsand R; Särnstrand B
Acta Derm Venereol Suppl (Stockh); 1989; 151():37-46; discussion 47-52. PubMed ID: 2624065
[TBL] [Abstract][Full Text] [Related]
38. [On an improved device for measuring skin tearing strength. Technical description and experimental results obtained from rat skin following therapy with topical corticoids (author's transl)].
Weishaupt W; Mengel K; Josefiuk P; Kapp JF
Arzneimittelforschung; 1977; 27(11a):2203-6. PubMed ID: 580029
[TBL] [Abstract][Full Text] [Related]
39. Activity of topically applied methylprednisolone aceponate in relation to other topical glucocorticosteroids in healthy volunteers.
Kecskés A; Jahn P; Wendt H; Kleine-Kuhlmann R; Lange L
Arzneimittelforschung; 1993 Feb; 43(2):144-7. PubMed ID: 8457237
[TBL] [Abstract][Full Text] [Related]
40. Penetration of mucopolysaccharides into the skin of diverse animal species.
Elling H
Arzneimittelforschung; 1986 Oct; 36(10):1525-7. PubMed ID: 2949755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
